ARCHIVES

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

New Center Plan Discussed By NAB, Directors Committees

May 4, 1990

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

TV Networks Donate A Prime-Time Hour To Raise Funds For Cancer Research; AACR To Administer Funds, Select Research “Dream Teams.”

May 30, 2008

Executive Summary of Centers, SPOREs Report

February 28, 2003

On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases

October 1, 1999